Author(s): Srikanta Chandra, Avik Das, Tathagata Roy, Preeta Bose, Susanta Paul, Lucky Mukherjee, Arijit Das

Email(s): troy@jisuniversity.ac.in

DOI: 10.5958/0974-360X.2021.00321.8   

Address: Srikanta Chandra1, Avik Das2, Tathagata Roy3, Preeta Bose3, Susanta Paul3, Lucky Mukherjee4, Arijit Das5
1Assistant Professor, Jakir Hossain Institute of Pharmacy, Department of Pharmacology, Raghunathganj, Murshidabad, 742225.
2Assistant Professor, Gupta College of Technological Sciences, Department of Pharmacology, Asansol, West Burdwan, West Bengal, 713301.
3Department of Pharmaceutical Technology, JIS University, Kolkata-700109.
4Assistant Professor, Sister Nivedita University, Kolkata.
5Assistant Professor, Bharat Technology, Uluberia, Howrah.
*Corresponding Author

Published In:   Volume - 14,      Issue - 3,     Year - 2021


ABSTRACT:
Inflammatory bowel disease is looming large on the modern society which has raised the brows of the medical scientists in both the developed and developing countries. According to American Gastrological Society (AGS) IBD is defined acute or chronic idiopathic ulceroinflammatory condition of the bowel which may or may not have transmural stretch. IBD encompasses two pivotal kinds of pathological condition Ulcerative colitis (UC) and Crohn’s disease (CD). Epidemiologically UC has a greater prevalence in the global prospective. So we decided to zero in on UC in our work ahead. Pivotal contours may be featured as toxic megacolon, pseudopolyps and backwash ileitis. The featured encountered in the clinical course of the disease are multiferrous spanning from rectal bleeding, abdominal pain, weight loss and malasei. Coming to the option available for management they include both non pharmacological approach and pharmacological approach. Under the nonpharmacological approach life style changes like monitored dieting, exercise may plays a pivotal role and psychological intervention also deployed to control the functional aspects of the disease. On the other hand Salfasalazine and Mesalamine are still considered as a corner stone of the therapy as per as pharmacological approach.


Cite this article:
Srikanta Chandra, Avik Das, Tathagata Roy, Preeta Bose, Susanta Paul, Lucky Mukherjee, Arijit Das. Emergent Strategy in Management of Inflammatory Bowel Disease: A Narrowed in on Novel Drugs. Research J. Pharm. and Tech. 2021; 14(3):1811-1814. doi: 10.5958/0974-360X.2021.00321.8

Cite(Electronic):
Srikanta Chandra, Avik Das, Tathagata Roy, Preeta Bose, Susanta Paul, Lucky Mukherjee, Arijit Das. Emergent Strategy in Management of Inflammatory Bowel Disease: A Narrowed in on Novel Drugs. Research J. Pharm. and Tech. 2021; 14(3):1811-1814. doi: 10.5958/0974-360X.2021.00321.8   Available on: https://rjptonline.org/AbstractView.aspx?PID=2021-14-3-110


REFERENCES:
1.    H. Konstantinos Katsanos, A. Konstantinos Papadakis. Inflammatory Bowel Disease: Updates on Molecular Targets for Biologics; Gut and Liver. Indian Journal of Pharmaceutical Science. 2017; 11(4): 455-463
2.    A. Kathleen, Jurenka. S Julie. Inflammatory Bowel Disease Part I: Ulcerative Colitis-Pathophysiology and Conventional and Alternative Treatment Options. Altern Med Rev. 2003; 8(3): 247 -283
3.    J Babickova, A. Hyosin. Pathological and therapeutic interactions between bacteriophages, microbes and the host in inflammatory disease. World Journal of Gastroenterology .2015;16(2): 452-458
4.    Khor Bernard, Gardet Agnes, Xavier. J Amnik. Genetics and pathogenesis of inflammatory bowel disease. International Journal of Pharmaceutical Science .2011: 17(2): 307-317
5.    Autenrieth .M Daniel, Baumgart .C Daniel. Toxic Megacolon, Inflammatory Bowel Disease. Journal of Gastroenterology. 2012; 18(3): 212-219
6.    Ravikumar. M, Sandhu K. B. Epidemiology of IBD in childhood. Indian Journal of Pediatrics .2006; 73(8) :717-72
7.    Campos -Sales .H, Basso. J.P, Alves F.B.V, Fonseca. C. T M, Bonfa G, Nardini V, Cardoso. B.R.C. Classical and recent advances in the treatment of inflammatory bowel diseases. Brazilian Journal of Medical and Biological Research. 2015; 48(2): 96 -107
8.    Lee Sun Hyo, Park -Kyung -Soo, Park Dong I1. Novel treatments for inflammatory bowel disease. The Korean Journal of International Medicine. 2018; 33(1):20-27.
9.    A. Katheen, Jurenka. S Julie. Inflammatory Bowel Disease Part I: Ulcerative Colitis–Pathophysiology and Conventional and Alternative Treatment Options. Altern Med Rev .2003; 8(3): 247 -283
10.    Narula Neeraj, Rubin. T David, Sands E. Bruce. Novel Therapies in Inflammatory Bowel Disease: An Evaluation of the Evidence. The American Journal of Gastrology Supplements .2016; 3 (2): 38-44
11.    Patel MA, Patel PK, Patel MB. Aqueous Extract of Ficus bengalensis Linn. Bark for Inflammatory Bowel Disease. Journal of Young Pharmacy. 2010; 2(2): 130-136
12.    12.Skroza Nevena, Proietti Ilaria, Pampena Riccardo, Viola La Giorgio, Bernardini Nicoletta, Nicolucci Francesca, Tolino Ersillia, Zuber Sara, Soccodata Valentina, Potenza Concetta. Correlations between Psoriasis and Inflammatory Bowel Diseases. Biomed Research International. 2013; 5(2): 87-95
13.    Kim Youjin, Wu G. Alex, Chimedza–Jaja Asha, Graf L. Brittany, Carrie Waterman, et al. Isothiocyanate –enriched Moringa seed extract alleviates ulcerative colitis symptoms in mice. World Journal of Gastroenterology. 2017: 3(2): 410-418
14.    Elmasry Ahlam, Daba –Hesham Mohamed, Karef -A. El Amro. Possible Effects of Moringa oleifera versus Ginger (Zingiber officinalis) on Experimental Colitis in Mice. British Journal of Medicine and Medical Research. 2016: 16(2): 1-19
15.    Minaiyan Mohsen, Asghari Ghloamreza, Taheri Diana, Saeidi Mozhgan, Esfahani Nasr Salar. Anti –inflammatory effect of Moringa oleifera Lam. Seeds on acetic acid –induced acute colitis in rats. Avicenna Journal of Phytomedicine. 2014: 4(2): 127-136
16.    16.MENG-Yue Wan, QING –You Zhu, BING Xia, JUN Luo. Treating TNBS –Induced colitis in rats with probiotics. Turkey Journal of Gastroenterology. 2011: 22(5): 486-493
17.    17.Rejaie S AL-Salim, Abuohasish M Hatem, Enazi M Al- Mahar, Assaf H Al-Abdullah, M Parmar Y Mihir, et al. Protective effect of naringenin on acetic acid –induced ulcerative colitis in rats; World Journal of Gastroentroenterology. 2013: 19(34): 5633-5644
18.    Somani S J, Badgujar L B, Sutariya B K, Saraf M N. Protective effect of Dillenia indica L. acetic acid induced colitis in mice. Indian Journal of Experimental Biology. 2014: 52 (4): 876-881

Recomonded Articles:

Author(s): Niha Naveed, Karthikeyan Murthykumar, Subasree Soundarajan, Sripradha Srinivasan

DOI: Not Available         Access: Open Access Read More

Author(s): Prasad V. Patrekar, Sachin S. Mali

DOI: Not Available         Access: Open Access Read More

Author(s): Koushika Das, Pranit Krishna, Avipsha Sarkar, Shanmuga Sundari Ilangovan, Shampa Sen

DOI: 10.5958/0974-360X.2017.00267.0         Access: Open Access Read More

Author(s): U.S Mahadeva Rao, Khamsah Suryati Mohd, Abdurrazaq Muhammad, Bashir Ado Ahmad, Mohaslinda Mohamad, Rosmawati Mat Ali

DOI: Not Available         Access: Open Access Read More

Author(s): Yarnykh T. G., Kotvitska A. A., Tykhonov A. I., Rukhmakova O. A.

DOI: 10.5958/0974-360X.2020.00614.9         Access: Open Access Read More

Author(s): Shrivastava Alankar, Jain R., Agrawal R.K., Ahirwar D.

DOI:         Access: Open Access Read More

Author(s): Gopinath G, Thirumal M, P. R. Kumar

DOI: 10.5958/0974-360X.2020.00362.5         Access: Open Access Read More

Author(s): Avinash Bhagwat, Suhas M Kakade, Chirag V Naval, Mukesh Tilker, Ravindra M Walture, Sagar A Adichwal and Atul P Chaudhari

DOI: Not Available         Access: Open Access Read More

Author(s): M. Sumithra, Avantika Prabhabanik

DOI: 10.5958/0974-360X.2017.00036.1         Access: Open Access Read More

Author(s): Manoj S. Pagare, Leena Patil, Vilasrao J. Kadam

DOI: Not Available         Access: Open Access Read More

Author(s): D. Benito Johnson, Appalaraju Gorle

DOI: Not Available         Access: Open Access Read More

Author(s): A. Julius, Ramachandran Vedasendiyar, Archana Devakannan, Sujatha Rajaraman, Balamurugan Rangasamy, V. Saravanan

DOI: 10.5958/0974-360X.2017.00062.2         Access: Open Access Read More

Author(s): A. Rajendra Kumar, N. J. Muthukumar, A. Faridha

DOI: 10.5958/0974-360X.2019.00081.7         Access: Open Access Read More

Author(s): Kousalya M., Geetha P., Jesuraja A., Vinoth Kumar M

DOI: 10.5958/0974-360X.2017.00014.2         Access: Open Access Read More

Author(s): Neha Rajput, Dinesh Sachan, Shikha Gangwar, Dipti Sachan

DOI: Not Available         Access: Open Access Read More

Author(s): Mohammed Ehtesham Ur Rahman, Mohammed Abdul Haseeb, Mohammed Saleem, Abdul Naveed

DOI: Not Available         Access: Open Access Read More

Author(s): Suleiman Danladi, Mohammed Alkassim Hassan, Idris Aliyu Masa’ud, Umar Idris Ibrahim

DOI: 10.5958/0974-360X.2018.00768.0         Access: Open Access Read More

Author(s): Uday Gaikwad, Milind Parle

DOI: Not Available         Access: Open Access Read More

Research Journal of Pharmacy and Technology (RJPT) is an international, peer-reviewed, multidisciplinary journal.... Read more >>>

RNI: CHHENG00387/33/1/2008-TC                     
DOI: 10.5958/0974-360X 

0.38
2018CiteScore
 
56th percentile
Powered by  Scopus


SCImago Journal & Country Rank


Recent Articles




Tags